期刊文献+

六味地黄丸对甲状腺素所致甲亢大鼠脂肪组织UCP2、骨骼肌UCP3mRNA表达的影响 被引量:4

Effects of Liuwei Dihuang Pills on the Expression of Adipose Tissue UCP2 mRNA and Skeletal Muscle UCP3 mRNA in Hyperthyroid Rats Induced by Thyroxine
暂未订购
导出
摘要 目的:探讨六味地黄丸对甲状腺素所致甲亢大鼠脂肪组织UCP2、骨骼肌UCP3mRNA表达的影响。方法:雄性SD大鼠48只,随机分为空白组、甲状腺素甲亢模型组、甲状腺素+低剂量六味地黄丸组和甲状腺素+高剂量六味地黄丸组,每组12只。利用RT-PCR测定各组大鼠脂肪组织UCP2与骨骼肌UCP3mRNA表达,并检测各组大鼠血清T3、T4,红细胞Na+-K+-ATP酶活力,肝脏MDA含量和SOD活力。结果:与甲状腺素甲亢模型组相比,甲状腺素+高剂量六味地黄丸组大鼠脂肪组织UCP2和骨骼肌UCP3mRNA表达水平显著下调(P<0.05),红细胞Na+-K+-ATP酶活力降低(P<0.05),血清T3、T4以及肝组织MDA含量显著降低(P<0.01),肝脏SOD活力显著增加(P<0.01);甲状腺素+低剂量六味地黄丸组甲亢大鼠脂肪组织UCP2表达水平下调,但差异无统计学意义(P>0.05),骨骼肌UCP3mRNA表达水平显著下调(P<0.05),血清T(3P<0.05)、T4以及肝组织MDA含量显著降低(P<0.01),红细胞Na+-K+-ATP酶活力降低,但差异无统计学意义(P>0.05),肝脏SOD活力显著增加(P<0.01)。结论:六味地黄丸可以下调甲状腺素所致甲亢大鼠脂肪组织UCP2和骨骼肌UCP3mRNA表达。 Objective: To observe the effects of Liuwei Dihuang pills on the expression of UCP2 mRNA of adi- pose tissue and UCP3 mRNA of skeletal muscle in hyperthyroid rats induced by Thyroxine. Methods: For- ty-eight male SD rats were randomly divided into blank control group, hyperthyroid model of thyroxine group, thy- roxine plus low-dose Liuwei Dihuang pills group, and thyroxine plus high-dose Liuwei Dihuang pills group, 12 rats in each. The expression of UCP2 mRNA of adipose tissue and UCP3 mRNA of skeletal muscle in rats of all groups were detected by RT-PCR. The serum T3 and T4 and Na+-K+-ATPase activity of red blood cells, MDA content and SOD activity of liver were measured. Results: Compared with the hyperthyroid model of thyrox- ine group, the thyroxine plus high-dose Liuwei Dihuang pills group had reduced expression of UCP2 mRNA and UCP3 mRNA (P 〈 0.05), decreased Na +-K +-ATPase activity (P 〈 0.05), lower serum T3 and T4 and liver MDA content(P〈0.01), and increased SOD activity(P〈0.01); thyroxine plus low-dose Liuwei Dihuang pills group al- so had reduced expression of UCP2 mRNA in number (P〉0.05)and down-regulated UCP3 mRNA with a signifi- cant difference (P〈0.05), lower serum T3 and T4 content and liver MDA content (P〈0.05), decreased Na+-K +-ATPase activity in number (P〉0.05), and increased SOD activity(P〈0.01). Conclusion: Liuwei Di- huang Pills can down-regulate the expression of UCP2 mRNA of adipose tissue and UCP3 mRNA of skeletal muscle in hyperthyroid rats induced by thyroxine.
机构地区 浙江中医药大学
出处 《浙江中西医结合杂志》 2012年第11期849-852,共4页 Zhejiang Journal of Integrated Traditional Chinese and Western Medicine
基金 浙江省教育厅科研基金(No.20050827)
关键词 大鼠 甲亢 六味地黄丸 UCP2 UCP3 rats hyperthyroidism Liuwei Dihuang pills UCP2 UCP3
  • 相关文献

参考文献10

  • 1Jezek P. Possble physiological roles of mitochondrial uncou-pling proteins-UCPn [J]. Biochem Cell Biol, 2002, 34:1190-1206.
  • 2Pecqueur C,Aives-Guerra M, Geliy C, et al. uncoupling pro-tein 2,in vivo diatribution,induction upon oxidative stress,and evidence for translational regulation [J].J Biol Chem,2001,276(12):8705-8712.
  • 3Esterbauer H.The uncoupling protein-3 gene is transcribedfrom tissue-specific promoters in humans but not in rodents[J], Biol Chem,2000,275(46) :36394-36399.
  • 4Insurk J, DaeYeon H, Jueun L. Physiological difference be-tween dietary obesity-susceptible and obesity-resistantsprague dawley rats in response to moderate high fat diet[j].Exp Anim.2003,52(2):99-107.
  • 5张子泰,侯英萍,汪静,林国成,宋武战,邓敬兰.用左旋T_4建立大鼠甲状腺功能亢进模型的实验研究[J].西北国防医学杂志,2006,27(1):34-36. 被引量:16
  • 6曾林,曲在屏,李劲松,曹永成,徐兴钊,李学勇.大鼠甲亢模型的建立[J].实用医药杂志,1997,0(5):45-45. 被引量:5
  • 7陈奇.中药药理研究方法学[M].北京:人民卫生出版社,1992.44.
  • 8伊迎春,林汉华.甲状腺素对大鼠脂肪组织解偶联蛋白-2基因表达的影响[J].医药导报,2003,22(6):369-371. 被引量:2
  • 9Lanni A, Moreno M, Lombardi A, et al.Thyroid hormone anduncoupling proteins[J].FEBS Lett,2003,543(1 -3) :5-10.
  • 10胡方林,刘仙菊,易法银,阳春林,龙玲.益气滋阴方调节甲亢模型大鼠甲状腺激素的实验研究[J].现代中西医结合杂志,2008,17(25):3902-3903. 被引量:3

二级参考文献21

  • 1刘安丽,贺生.家兔实验性甲亢心肌形态学观察[J].实验动物科学,1991,22(3):22-23. 被引量:2
  • 2梁晓萍,原丽萍,王雪圃,罗贵有,吴夏夏,丁建中.人类放免药盒测定正常大鼠血中T_3、T_4、皮质醇水平的探讨[J].中国比较医学杂志,1991,0(Z1):121-121. 被引量:2
  • 3赵桂云,王海生,赵桂香.FT_3、FT_4 RIA在突眼患者中的临床应用[J].放射免疫学杂志,2007,20(1):53-53. 被引量:6
  • 4Klein I,Ojamaa K.Thyroid hormone:targeting the vascular smooth muscle cell[J].Circ Res,2001 Feb 16,88(3):260-264.
  • 5Fukuyama K,Ichiki T,Takeda K,et al.Downregulation of Vascular Angiotensin II Type 1 Receptor by Thyroid Hormone[J].Hypertension,2003,41:598-603.
  • 6Serafino F,Emiliano A.Palmieri,et al.Effects of Thyroid Hormone on the Cardiovascular System[J].Recent Progress in Hormone Research,2004,59:31-50.
  • 7Marchant C,Brown L,Sernia C.Renin-angiotensin system in thyroid dysfunction in rats[J].Cardiovasc Pharmacol,1993,22:449-455.
  • 8Raffaele N,Bernadette B,Vincenzo G,et al.Impact of Hyperthyroidism and Its Correction on Vascular Reactivity in Humans[J].Circulation,2001,104:3076-3080.
  • 9Kiselev VI,Treshutin VA.Role of the blood kallikrein-kinin system in activating hemodynamic effects induced by L-thyroxine[J].Probl Endokrinol(Mosk),1982,28(1):78-81.
  • 10Hu LW,Benvenuti LA,Liberti EA,et al.Thyroxineinduced cardiac hypertrophy:influence of adrenergic nervous system versus renin-angiotensin system on myocyte remodeling[J].Physiol Regul Integr Comp Physiol,2003,285:R1473-R1480.

共引文献105

同被引文献91

引证文献4

二级引证文献58

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部